Impact of a Multicomponent Exercise Program on Cognitive and Functional Outcomes in Patients With Mild Cognitive Impairment
Eligible age
50+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this randomised clinical trial is to investigate the effectiveness of an innovative therapeutic exercise program emphasizing in dual-task exercises in people with amnestic Mild Cognitive Impairment. The main questions it aims to answer are: Does the innovative therapeutic exercise program improve gait and balance? Does the innovative therapeutic exercise program improve cognition? Researchers will compare the innovative therapeutic exercise program emphasizing in dual-task exercises to a therapeutic exercise program without emphasizing in dual-task exercises and to a control group (given instruction about the benefits of exercise). Participants will: * Perform the exercise program twice a week for three months. * Will be assessed before and after the intervention. * Will record The Borg Scale of Perceived Exertion every second week to monitor and assess the progression of exercise intensity.
Sponsor: University of Patras
You may qualify if…
- ✓ individuals \> 50 years old
- ✓ people with confirmed cognitive impairment, as evidenced by values within normal limits on the Montreal Cognitive Assessment test (MOCA ) \>20
- ✓ stable medication in the last month
- ✓ independent walking
You may not qualify if…
- ✕ people with dementia
- ✕ people suffering from chronic mental illness (e.g. schizophrenia, bipolar disorder)
- ✕ people suffering from a neurological disorder or injuries (e.g. multiple sclerosis, Parkinson's, traumatic brain injury)
- ✕ people with clinical depression (as determined by the Neuropsychiatric Inventory (NPI) assessment and medical diagnosis)
- ✕ people who have had recent surgery
- ✕ people with insufficient knowledge of the Greek language
Source: ClinicalTrials.gov · NCT07334392 · last updated 2026-01-12